Pyrimidine nucleoside and nucleotide research compounds · Fact sheet

Uridine

Also known as Uridine-5-monophosphate · UMP

Uridine is a nucleoside involved in RNA and phospholipid-related metabolism. A seven-person uncontrolled bipolar-depression report and animal UMP studies do not establish a cognitive-enhancement regimen.

Not FDA approvedLimited or unclear evidence

What is Uridine?

Uridine and uridine monophosphate are related but distinct forms that require formulation-specific interpretation.

Approved uridine-triacetate products are separate medicines; their labeling cannot validate a uridine supplement regimen.

Benefits & claims

Interest in Uridine spans cognition and sleep. Study findings apply to the named formulation and population.

What the evidence supports

  • The adolescent report described lower depressive symptoms but had no placebo group.
  • Gerbil UMP studies explored phospholipid precursors and combination effects with DHA.
  • These findings do not establish human memory enhancement or a generally effective mood treatment.
Research areas
  • Formulation-specific human outcomes
  • Mechanistic research

Dosage & frequency

No established human regimen

The reviewed sources do not establish a human treatment amount or frequency for Uridine. Animal and laboratory exposures are not human regimens.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Identity and pharmacology
Uridine and uridine monophosphate are related but distinct forms that require formulation-specific interpretation.

Formulation differences

  • Approved uridine-triacetate products are separate medicines; their labeling cannot validate a uridine supplement regimen.

Interactions & precautions

  • The reviewed sources do not establish a comprehensive human interaction profile for this exact substance or combination.

What is still unresolved

  • Reproducibility in larger independent trials
  • Long-term outcomes and adverse effects
  • Equivalence of different preparations and interaction profiles

Side effects & risks

  • Safety in bipolar disorder and with psychiatric medicines cannot be established by a seven-person series.
  • Different uridine forms and combination supplements can change exposure and make outcome attribution difficult.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Limited or unclear evidence

The direct mood report was an open-label case series of seven adolescents. The membrane-biochemistry and learning studies cited here used gerbils and sometimes additional nutrients.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

No attributable personal accounts were found in the sources reviewed.

Approval status

No FDA-approved Uridine drug indication is established for the supplement uses discussed here. Supplement availability is not FDA approval of efficacy or safety.

No FDA-approved product for this entry

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Reproducibility in larger independent trials
  • Long-term outcomes and adverse effects
  • Equivalence of different preparations and interaction profiles

Summary

These findings do not establish human memory enhancement or a generally effective mood treatment.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. pubmedOpen-label uridine for treatment of depressed adolescents with bipolar disorder.

    Seven adolescents; uncontrolled six-week case series.

  2. pubmedUMP and gerbil brain phospholipid precursors

    Animal biochemical study.

  3. pubmedUridine plus DHA in gerbil learning

    Animal combination experiment; not isolated human uridine efficacy.

How we assess sources · Suggest a correction